Skip to content

Sulfinpyrazone

Anturane (sulfinpyrazone) is a small molecule pharmaceutical. Sulfinpyrazone was first approved as Anturane on 1982-01-01. It is used to treat angina pectoris, coronary disease, gout, and myocardial infarction in the USA. The pharmaceutical is active against solute carrier family 22 member 12. In addition, it is known to target fMet-Leu-Phe receptor.
Trade Name Anturane
Common Name Sulfinpyrazone
Indication angina pectoris, coronary disease, gout, myocardial infarction
Drug Class
Sulfinpyrazone
Get full access now